The Efficacy and Safety of Topiramate in the Prevention of Pediatric Migraine: An Update Meta-Analysis
Background: Migraine is the most common acute primary headache in children and adolescents. In 2014, topiramate became the first preventive drug for migraine, approved by the Food and Drug Administration (FDA) for adolescents. This meta-analysis was aimed to evaluate the efficacy and safety of topir...
Saved in:
Main Authors: | Xinwei Wu (Author), Yan Zhang (Author), Mei Lu (Author), Xiaolin Yu (Author), Xiang Ye (Author), Xingbang Wang (Author), Peiyan Shan (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Topiramate in Pediatric Migraine
by: J Gordon Millichap
Published: (2009) -
Prophylatic treatment of migraine and migraine clinical variants with topiramate: an update
by: Sergio Carmona, et al.
Published: (2009) -
Topiramate and Cognitive Function in Migraine
by: J Gordon Millichap
Published: (2010) -
Topiramate-Induced Cough in Migraine Prophylaxis
by: J Gordon Millichap
Published: (2009) -
Alice in Wonderland Syndrome Asociated with Topiramate for Adolescent Migraine Prevention
by: J Gordon Millichap
Published: (2011)